Dishman Carbogen Amcis Ltd Share Price
(DCAL)
₹208.92
as on 04:01PM, 23 Apr 2025
Dishman Carbogen Amcis Ltd Performance
Day's Low
Day's High
₹208.5Day's Price Range₹216.252 Week's Low
52 Week's High
₹13352-Week Price Range₹307.98
| Returns % | |
| 1 Month Return | -10.38 % |
| 3 Month Return | -11.62 % |
| 1 Year Return | -10.51 % |
| Market Stats | |
| Previous Close | ₹212.60 |
| Open | ₹213.20 |
| Volume | 3.68L |
| Upper Circuit | ₹255.12 |
| Lower Circuit | ₹170.08 |
| Market Cap | ₹3,275.51Cr |
Dishman Carbogen Amcis Ltd Fundamentals
P/E Ratio
-29.85
PEG Ratio
-10.51
Market Cap
₹3,275.51 Cr
P/B Ratio
0.91
EPS
-9.79
Dividend Yield
0Sector
Pharmaceuticals
ROE
0Mutual Fund Holdings of Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis Ltd Share analysis
Excluding Excise Duty and Other Income, represents Net Revenue
Dishman Carbogen Amcis Ltd revenue growth forecast
Expected growth rate Q1, FY2023:
Forecast
Actual
Including amortisation and stock based compensations
Dishman Carbogen Amcis Ltd EPS growth forecast
EPS estimate Q1, FY2023:
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Dishman Carbogen Amcis Ltd
Dishman Carbogen Secures Drug License, Shares Surge - 11 Apr, 2025
Dishman Carbogen Amcis Ltd's subsidiary received a drug manufacturing license from NMPA in China, leading to significant share price increases of 5% and 10%. The company aims for revenue growth and improved EBITDA margins in the coming years.Dishman Carbogen Amcis Secures Drug Manufacturing License in China - 09 Apr, 2025
Dishman Carbogen Amcis Ltd's subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., has received a Drug Manufacturing License from China's NMPA, enabling regulatory-compliant manufacturing operations in Shanghai. This milestone enhances the company's international manufacturing capabilities.Dishman Carbogen Amcis Allocates INR 50 Crore in Debentures - 26 Mar, 2025
Dishman Carbogen Amcis Limited has allotted 5,000 non-convertible debentures worth INR 50 crore to raise capital through private placement, enhancing financial stability.Dishman Carbogen Reports Growth and GMP Compliance - 20 Mar, 2025
Dishman Carbogen Amcis Ltd's subsidiary received a GMP compliance certificate for its French site. The company reported a 4.8% increase in net sales for December 2024, with a substantial rise in net profit and EBITDA.Dishman Carbogen Amcis Approves ₹50 Crore Debenture Issuance - 13 Mar, 2025
Dishman Carbogen Amcis Ltd's shares increased by 1.90% following the board's approval for ₹50 crore in non-convertible debentures, enhancing liquidity and capital structure.
Insights on Dishman Carbogen Amcis Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 1.03% to 1.22% in Dec 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 8.17% to 8.74% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 65.1%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 115.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.32% of holdings in Dec 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 31.28% to 30.51% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 795.69 Cr → 690.01 Cr (in ₹), with an average decrease of 13.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, DCAL stock has moved down by -8.8%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 33.09 Cr → 4.63 Cr (in ₹), with an average decrease of 86.0% per quarter
Dishman Carbogen Amcis Ltd Financials
Dishman Carbogen Amcis Ltd Index Inclusions
Dishman Carbogen Amcis Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 59.32% | 0.00 | |
| Foreign Institutions | 8.74% | 7.01 | |
| Mutual Funds | 1.22% | 18.63 | |
| Retail Investors | 30.51% | ||
| Others | 0.2% | 0.05 |
Dishman Carbogen Amcis Ltd Key Indicators
Dishman Carbogen Amcis Ltd Valuation
Dishman Carbogen Amcis Ltd in the last 5 years
Lowest (-599.35x)
March 22, 2023
Today (-29.85x)
April 23, 2025
Industry (53.87x)
April 23, 2025
Highest (338.29x)
July 25, 2022
Dishman Carbogen Amcis Ltd Earnings and Dividends
Dishman Carbogen Amcis Ltd Earnings Results
Dishman Carbogen Amcis Ltd’s net profit jumped 107.76% since last year same period to ₹4.63Cr in the Q3 2024-2025. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated -86.01% fall in its net profits since last 3-months.
Read More about Earnings ResultsDishman Carbogen Amcis Ltd Dividends May,2019
In the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 - translating a dividend yield of 0.10%.
Read More about Dividends
Dishman Carbogen Amcis Ltd Technicals Summary
Bearish
Neutral
Bullish
Dishman Carbogen Amcis Ltd is currently in a Bearish trading position according to technical analysis indicators.
Dishman Carbogen Amcis Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹3,275.51 Cr | 28.33% | 0.58 | -₹154 Cr | ₹2,615 Cr | |
| NA | ₹11.15 Cr | 66.72% | 0.50 | NA | NA | |
| NA | ₹2,987.44 Cr | 39.26% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| NA | ₹520.52 Cr | 260.56% | 0.73 | ₹7 Cr | ₹1 Cr | |
| NA | ₹157.93 Cr | 105.19% | 0.69 | NA | NA |
About Dishman Carbogen Amcis Ltd
Revenue: ₹682.34Cr as on December 2024 (Q4 24)
Net Profit: ₹4.63Cr as on December 2024 (Q4 24)
Listing date: 21 Sep, 2017
Chairperson Name: Janmejay R Vyas
| Organisation | Dishman Carbogen Amcis Ltd |
| Headquarters | Gujarat |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Dishman Carbogen Amcis Ltd
What is Dishman Carbogen Amcis Ltd price today?
Dishman Carbogen Amcis Ltd share price today stands at ₹208.92, Open: ₹213.2, Previous Close: ₹212.6, High: ₹216.2, Low: ₹208.5, 52 Week High: ₹307.98, 52 Week Low: ₹133.
How to Buy Dishman Carbogen Amcis Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Dishman Carbogen Amcis Ltd shares
What are today's traded volumes of Dishman Carbogen Amcis Ltd?
Today's traded volume of Dishman Carbogen Amcis Ltd(DCAL) is 3.68L.
What is today's market capitalisation of Dishman Carbogen Amcis Ltd?
Today's market capitalisation of Dishman Carbogen Amcis Ltd(DCAL) is ₹3275.51Cr.
What is the 52 Week High and Low Range of Dishman Carbogen Amcis Ltd?
How much percentage Dishman Carbogen Amcis Ltd is down from its 52 Week High?
Dishman Carbogen Amcis Ltd (DCAL) share price is ₹208.92. It is down -32.16% from its 52 Week High price of ₹307.98
How much percentage Dishman Carbogen Amcis Ltd is up from its 52 Week low?
Dishman Carbogen Amcis Ltd (DCAL) share price is ₹208.92. It is up 57.08% from its 52 Week Low price of ₹133